Acme United Corporation
Acme United Corporation (ACU) Stock Competitors & Peer Comparison
See (ACU) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACU | $43.69 | +0.00% | 172.2M | 18.47 | $2.45 | +1.39% |
| PG | $158.56 | +0.00% | 375.7B | 23.82 | $6.75 | +2.63% |
| UL | $72.01 | +0.00% | 160.1B | 24.49 | $2.99 | +3.13% |
| CL | $93.98 | +0.00% | 76.6B | 36.15 | $2.63 | +2.19% |
| EL | $111.74 | +0.00% | 41.2B | -228.42 | -$0.50 | +1.24% |
| KMB | $108.68 | +0.00% | 36.2B | 22.43 | $4.86 | +4.62% |
| KVUE | $18.66 | +0.00% | 35.9B | 24.66 | $0.76 | +4.41% |
| CHD | $103.25 | +0.00% | 24.8B | 34.14 | $3.02 | +1.16% |
| SGI | $89.45 | +0.00% | 19.1B | 58.07 | $1.57 | +0.66% |
| CLX | $122.22 | +0.00% | 15.1B | 20.23 | $6.11 | +4.01% |
Stock Comparison
ACU vs PG Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, PG has a market cap of 375.7B. Regarding current trading prices, ACU is priced at $43.69, while PG trades at $158.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas PG's P/E ratio is 23.82. In terms of profitability, ACU's ROE is +0.09%, compared to PG's ROE of +0.31%. Regarding short-term risk, ACU is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PG's competition here
ACU vs UL Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, UL has a market cap of 160.1B. Regarding current trading prices, ACU is priced at $43.69, while UL trades at $72.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas UL's P/E ratio is 24.49. In terms of profitability, ACU's ROE is +0.09%, compared to UL's ROE of +0.36%. Regarding short-term risk, ACU is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UL's competition here
ACU vs CL Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, CL has a market cap of 76.6B. Regarding current trading prices, ACU is priced at $43.69, while CL trades at $93.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas CL's P/E ratio is 36.15. In terms of profitability, ACU's ROE is +0.09%, compared to CL's ROE of +4.32%. Regarding short-term risk, ACU is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CL's competition here
ACU vs EL Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, EL has a market cap of 41.2B. Regarding current trading prices, ACU is priced at $43.69, while EL trades at $111.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas EL's P/E ratio is -228.42. In terms of profitability, ACU's ROE is +0.09%, compared to EL's ROE of -0.04%. Regarding short-term risk, ACU is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EL's competition here
ACU vs KMB Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, KMB has a market cap of 36.2B. Regarding current trading prices, ACU is priced at $43.69, while KMB trades at $108.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas KMB's P/E ratio is 22.43. In terms of profitability, ACU's ROE is +0.09%, compared to KMB's ROE of +1.55%. Regarding short-term risk, ACU is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KMB's competition here
ACU vs KVUE Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, KVUE has a market cap of 35.9B. Regarding current trading prices, ACU is priced at $43.69, while KVUE trades at $18.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas KVUE's P/E ratio is 24.66. In terms of profitability, ACU's ROE is +0.09%, compared to KVUE's ROE of +0.14%. Regarding short-term risk, ACU is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KVUE's competition here
ACU vs CHD Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, CHD has a market cap of 24.8B. Regarding current trading prices, ACU is priced at $43.69, while CHD trades at $103.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas CHD's P/E ratio is 34.14. In terms of profitability, ACU's ROE is +0.09%, compared to CHD's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CHD's competition here
ACU vs SGI Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, SGI has a market cap of 19.1B. Regarding current trading prices, ACU is priced at $43.69, while SGI trades at $89.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas SGI's P/E ratio is 58.07. In terms of profitability, ACU's ROE is +0.09%, compared to SGI's ROE of +0.13%. Regarding short-term risk, ACU is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SGI's competition here
ACU vs CLX Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, CLX has a market cap of 15.1B. Regarding current trading prices, ACU is priced at $43.69, while CLX trades at $122.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas CLX's P/E ratio is 20.23. In terms of profitability, ACU's ROE is +0.09%, compared to CLX's ROE of +15.02%. Regarding short-term risk, ACU is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CLX's competition here
ACU vs ELF Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, ELF has a market cap of 5.6B. Regarding current trading prices, ACU is priced at $43.69, while ELF trades at $91.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas ELF's P/E ratio is 53.10. In terms of profitability, ACU's ROE is +0.09%, compared to ELF's ROE of +0.11%. Regarding short-term risk, ACU is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check ELF's competition here
ACU vs NTCO Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, ACU is priced at $43.69, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas NTCO's P/E ratio is -11.37. In terms of profitability, ACU's ROE is +0.09%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NTCO's competition here
ACU vs IPAR Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, IPAR has a market cap of 3.3B. Regarding current trading prices, ACU is priced at $43.69, while IPAR trades at $101.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas IPAR's P/E ratio is 20.16. In terms of profitability, ACU's ROE is +0.09%, compared to IPAR's ROE of +0.20%. Regarding short-term risk, ACU is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check IPAR's competition here
ACU vs COTY Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, COTY has a market cap of 2.4B. Regarding current trading prices, ACU is priced at $43.69, while COTY trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas COTY's P/E ratio is -4.35. In terms of profitability, ACU's ROE is +0.09%, compared to COTY's ROE of -0.14%. Regarding short-term risk, ACU is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check COTY's competition here
ACU vs NWL Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, NWL has a market cap of 2B. Regarding current trading prices, ACU is priced at $43.69, while NWL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas NWL's P/E ratio is -7.18. In terms of profitability, ACU's ROE is +0.09%, compared to NWL's ROE of -0.11%. Regarding short-term risk, ACU is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NWL's competition here
ACU vs SPB Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, ACU is priced at $43.69, while SPB trades at $78.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas SPB's P/E ratio is 18.94. In terms of profitability, ACU's ROE is +0.09%, compared to SPB's ROE of +0.06%. Regarding short-term risk, ACU is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SPB's competition here
ACU vs EPC Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, EPC has a market cap of 1.1B. Regarding current trading prices, ACU is priced at $43.69, while EPC trades at $22.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas EPC's P/E ratio is 206.73. In terms of profitability, ACU's ROE is +0.09%, compared to EPC's ROE of -0.02%. Regarding short-term risk, ACU is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EPC's competition here
ACU vs HELE Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, HELE has a market cap of 427.3M. Regarding current trading prices, ACU is priced at $43.69, while HELE trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas HELE's P/E ratio is -0.54. In terms of profitability, ACU's ROE is +0.09%, compared to HELE's ROE of -0.68%. Regarding short-term risk, ACU is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check HELE's competition here
ACU vs NUS Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, NUS has a market cap of 420.1M. Regarding current trading prices, ACU is priced at $43.69, while NUS trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas NUS's P/E ratio is 2.75. In terms of profitability, ACU's ROE is +0.09%, compared to NUS's ROE of +0.20%. Regarding short-term risk, ACU is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NUS's competition here
ACU vs EWCZ Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, EWCZ has a market cap of 312.8M. Regarding current trading prices, ACU is priced at $43.69, while EWCZ trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas EWCZ's P/E ratio is 22.00. In terms of profitability, ACU's ROE is +0.09%, compared to EWCZ's ROE of +0.16%. Regarding short-term risk, ACU is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EWCZ's competition here
ACU vs PTNM Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, ACU is priced at $43.69, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas PTNM's P/E ratio is 346.33. In terms of profitability, ACU's ROE is +0.09%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, ACU is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PTNM's competition here
ACU vs SKIN Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, SKIN has a market cap of 119.9M. Regarding current trading prices, ACU is priced at $43.69, while SKIN trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas SKIN's P/E ratio is -5.87. In terms of profitability, ACU's ROE is +0.09%, compared to SKIN's ROE of -0.20%. Regarding short-term risk, ACU is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SKIN's competition here
ACU vs SLSN Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, SLSN has a market cap of 89.6M. Regarding current trading prices, ACU is priced at $43.69, while SLSN trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas SLSN's P/E ratio is 127.00. In terms of profitability, ACU's ROE is +0.09%, compared to SLSN's ROE of +0.07%. Regarding short-term risk, ACU is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SLSN's competition here
ACU vs GROV Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, GROV has a market cap of 62.9M. Regarding current trading prices, ACU is priced at $43.69, while GROV trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas GROV's P/E ratio is -2.37. In terms of profitability, ACU's ROE is +0.09%, compared to GROV's ROE of -1.87%. Regarding short-term risk, ACU is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check GROV's competition here
ACU vs AXIL Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, AXIL has a market cap of 37.8M. Regarding current trading prices, ACU is priced at $43.69, while AXIL trades at $5.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas AXIL's P/E ratio is 32.71. In terms of profitability, ACU's ROE is +0.09%, compared to AXIL's ROE of +0.14%. Regarding short-term risk, ACU is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check AXIL's competition here
ACU vs UG Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, UG has a market cap of 30.3M. Regarding current trading prices, ACU is priced at $43.69, while UG trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas UG's P/E ratio is 15.35. In terms of profitability, ACU's ROE is +0.09%, compared to UG's ROE of +0.18%. Regarding short-term risk, ACU is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UG's competition here
ACU vs MTEX Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, MTEX has a market cap of 13.3M. Regarding current trading prices, ACU is priced at $43.69, while MTEX trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas MTEX's P/E ratio is -8.15. In terms of profitability, ACU's ROE is +0.09%, compared to MTEX's ROE of -0.23%. Regarding short-term risk, ACU is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check MTEX's competition here
ACU vs RAY Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, RAY has a market cap of 10.9M. Regarding current trading prices, ACU is priced at $43.69, while RAY trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas RAY's P/E ratio is 5.35. In terms of profitability, ACU's ROE is +0.09%, compared to RAY's ROE of +0.09%. Regarding short-term risk, ACU is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check RAY's competition here
ACU vs DSY Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, DSY has a market cap of 10.2M. Regarding current trading prices, ACU is priced at $43.69, while DSY trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas DSY's P/E ratio is -0.45. In terms of profitability, ACU's ROE is +0.09%, compared to DSY's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSY's competition here
ACU vs PHH Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, ACU is priced at $43.69, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas PHH's P/E ratio is -0.53. In terms of profitability, ACU's ROE is +0.09%, compared to PHH's ROE of +0.38%. Regarding short-term risk, ACU is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PHH's competition here
ACU vs BRSH Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, ACU is priced at $43.69, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas BRSH's P/E ratio is -0.01. In terms of profitability, ACU's ROE is +0.09%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSH's competition here
ACU vs TANH Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, TANH has a market cap of 1.4M. Regarding current trading prices, ACU is priced at $43.69, while TANH trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas TANH's P/E ratio is -0.08. In terms of profitability, ACU's ROE is +0.09%, compared to TANH's ROE of +0.04%. Regarding short-term risk, ACU is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TANH's competition here
ACU vs TKLF Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, TKLF has a market cap of 1.2M. Regarding current trading prices, ACU is priced at $43.69, while TKLF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas TKLF's P/E ratio is 2.63. In terms of profitability, ACU's ROE is +0.09%, compared to TKLF's ROE of +0.16%. Regarding short-term risk, ACU is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TKLF's competition here
ACU vs BRSHW Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, ACU is priced at $43.69, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas BRSHW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.09%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSHW's competition here
ACU vs SUMR Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, ACU is priced at $43.69, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas SUMR's P/E ratio is -3.66. In terms of profitability, ACU's ROE is +0.09%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, ACU is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SUMR's competition here
ACU vs REV Comparison February 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 172.2M. In comparison, REV has a market cap of 0. Regarding current trading prices, ACU is priced at $43.69, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 18.47, whereas REV's P/E ratio is -1.19. In terms of profitability, ACU's ROE is +0.09%, compared to REV's ROE of +0.89%. Regarding short-term risk, ACU is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check REV's competition here